SIG | Seizures in Autoimmune Encephalitis: Updates in Autoimmune-Associated Seizure Disorders

Monday, December 7, 2026 at 4:00 PM to 5:30 PM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

This SIG discusses updates in evaluation and management of seizures associated with autoimmune encephalitis. The first talk discusses both seizure and non-seizure outcomes in LGI1-antibody and CASPR2-antibody encephalitis. This is followed by talks on GAD65-antibody-associated epilepsy and antibody-negative autoimmune-associated epilepsy. Our last speaker discusses imaging in autoimmune encephalitis, including a discussion of frequently acquired imaging studies in addition to novel imaging. At the end of the session, we have time for panel and audience discussion to allow for audience engagement in the session.
Learning Objective 1
Describe clinical presentation and prognosis of common autoimmune-associated seizure disorders
Learning Objective 2
Recognize the challenges in diagnosis and management of antibody negative autoimmune-associated epilepsy
Learning Objective 3
Describe common imaging findings in autoimmune-associated seizure disorders and the potential role of novel imaging techniques
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)NursesPharmacistsScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session ID
AUTOIMMUNESIG26
Presentation Id
3452257
Event ID
24056
Session Type
Session